Effect of DPC 333 [(2R)-2-{(3R)-3-Amino-3-[4-(2-methylquinolin-4-ylmethoxy)phenyl]-2-oxopyrrolidin-1-yl}-N-hydroxy-4-methylpentanamide], a Human Tumor Necrosis Factor α-Converting Enzyme Inhibitor, on the Disposition of Methotrexate: A Transporter-Based Drug-Drug Interaction Case Study
暂无分享,去创建一个
K. Brouwer | T. Maduskuie | C. Garner | C. Decicco | L. E. Richards | Jingwu Duan | L. Gan | Hanbo Hu | G. Luo | F. Lee | H. Xiong | Helen Shen